NGeneBio Co., Ltd. (KOSDAQ: A354200)
Health Care · Biotechnology · KR
₩937.00
+18.91% today · -80.6% 1Y
NGeneBio Co., Ltd. (KOSDAQ: A354200) operates in the Biotechnology industry within the Health Care sector. The company is valued at $11.31M.
Over the last twelve months the share price has lost 80.6%, trading between 633.00 and 8.29K.
Tweenvest scores NGeneBio Co., Ltd. across four factors: quality 28/100, value 59/100. Its strongest factor is value.
A354200 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.31M
- Revenue (TTM)
- $26.99M
- P/E
- —
- EPS
- -587.38
- Dividend yield
- —
- Beta (5Y)
- 0.94
- 52-week high
- ₩8,295.00
- 52-week low
- ₩633.00
- Avg volume (3M)
- —
- Shares outstanding
- 16.09M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eagle Pharmaceuticals, Inc.OTCPK: EGRX | $11.53M | $0.89 | -8.76% |
| Aelis Farma SAENXTPA: AELIS | $11.50M | €0.75 | -5.88% |
| Pluri Inc.NasdaqCM: PLUR | $11.48M | $0.93 | -2.44% |
| Celyad Oncology SAENXTBR: CYAD | $11.43M | €0.23 | +13.50% |
| Pharmigene, Inc.TPEX: 7595 | $11.28M | NT$7.25 | -2.03% |
| Passage Bio, Inc.NasdaqCM: PASG | $11.26M | $3.50 | -5.15% |
| Patrys LimitedASX: PAB | $11.06M | AU$0.03 | -3.57% |
| IN8bio, Inc.NasdaqCM: INAB | $10.94M | $1.11 | -17.16% |
Figures last refreshed Oct 18, 2026.